Alphabet, Tencent and Gilead Sciences are in line to achieve exits, after the vaccine developer filed to go public on the Nasdaq Global Market.

The NK cancer drug provider has filed to go public in an offering which would enable GC and its GC Labcell subsidiary to exit.

Autobio Diagnostics is set to exit the molecular diagnostic test provider through a purchase by women’s health-focused technology provider Hologic.

Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.

University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.

The Tencent-backed video game holding group has applied to float in a Korean initial public offering which could value it at about $18bn.

The cancer therapeutics developer has filed to float on the Nasdaq Global Market, with Taiho Ventures set to achieve an exit.

AgFunder is among the investors which have exited the agricultural robotics developer, which has been bought by AppHarvest.

Opt scored an exit as the jewellery subscription service was purchased by jewellery retailer Signet for an undisclosed sum.